• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cohance Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
1,043.50 -21 (-2.01%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    1,029.10

  • Today’s High

    1,066.00

  • Open

    1,065.10

  • Perv Close

    1,064.90

  • 52W Low

    835.10

  • 52W High

    1,360.00

Key Indicators

  • P/E(TTM)

    147.25

  • Mar.Cap (₹Cr.)

    39,920.88

  • Div & Yield %

    0.00

  • Book Value(₹)

    60.86

  • Debt-Equity Ratio

    -2.01

  • AGM Date

    23-Jul-2025

  • EPS

    7.10

  • P/E Ratio

    147.25

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    39,920.88

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    38.26

  • BV (₹)

    60.90

  • Sales( ₹ in Cr.)

    1,093.51

  • NP (in Cr.)

    271.71

  • NP Var(%)

    0.0

  • Div%

    0.0

  • CPS (₹)

    8.60

  • EPS (₹)

    7.10

  • Traded Value (₹ in Lakhs)

    39,995.48

  • 52 Week High

    1,360.00

  • 52 Week Low

    835.10

  • Price BSE

    1045.0

  • Price NSE

    1,044.00

  • Market Capital( in Cr.)

    39,995.48

  • P/C Ratio

    121.50

  • P/E Ratio

    147.10

  • Price Vs.BV

    7.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Other Income 55.09 44.55 187.79 14.24 18.12 0.60
Stock Adjustments -53.88 20.94 60.35 8.37 11.05 21.32
Total Income 1,026.20 1,395.57 1,568.36 1,032.33 862.96 399.75
EXPENDITURE :            
Raw Materials 248.38 421.36 459.46 310.32 240.24 124.52
Power and Fuel Cost 46.16 71.35 59.55 44.20 38.24 18.06
Employee Cost 126.88 108.58 100.48 76.23 65.10 29.63
Other Manufacturing Expenses 83.19 101.96 115.25 90.76 66.49 33.83
Selling and Administration Expenses 38.85 43.57 52.38 44.93 44.72 16.23
Miscellaneous Expenses 17.75 13.50 11.17 8.61 5.26 5.34
Employee Benefit Expenses 126.88 108.58 100.48 76.23 65.10 29.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 561.21 760.33 798.29 575.05 460.05 227.60
Operating Profit 465.00 635.24 770.08 457.28 402.91 172.15
Interest 7.43 12.75 8.53 11.66 21.81 2.79
Gross Profit 457.57 622.49 761.55 445.62 381.10 169.36
Depreciation 48.79 43.10 39.10 31.64 23.51 11.50
Profit Before Tax 408.78 579.39 722.45 413.98 357.59 157.86
Current Tax 97.37 142.45 157.63 101.72 88.81 33.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.59 4.34 6.72 3.62 -1.30 15.42
Reported Net Profit 304.82 432.60 558.10 308.65 270.08 109.27
Extraordinary Items 32.53 10.55 14.53 2.51 4.73 0.11
Adjusted Net Profit 272.29 422.05 543.57 306.14 265.35 109.16
Adjustment below Net Profit -0.30 -0.26 -0.76 -0.84 -13.90 315.80
P & L Balance brought forward 1,490.07 1,276.39 835.88 568.52 390.98 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 218.65 116.83 40.46 78.64 34.09
P & L Balance carried down 1,794.59 1,490.07 1,276.39 835.88 568.52 390.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 600.00 500.00 200.00 500.00 0.00
Dividend Per Share(Rs) 0.00 6.00 5.00 2.00 5.00 0.00
Earnings Per Share-Unit Curr 11.97 16.99 21.92 12.12 21.22 20.60
Earnings Per Share(Adj)-Unit Curr 11.97 16.99 21.92 12.12 10.61 -
Book Value 80.76 68.72 59.74 41.84 61.50 0.00
Book Value(Adj)-Unit Curr 80.76 68.72 59.74 41.84 30.75 -

Shareholding Pattern

  • Promoter Group

    66.41%

  • Public Share Holding

    33.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 254,078,170 66.41 254,078,170 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 254,078,170 66.41 254,078,170 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 37,834 0.01 37,834 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,644,995 7.23 27,644,995 158
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 8,698,387 2.27 8,698,387 15
Mutual Funds / UTI 34,048,214 8.90 34,012,214 26
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 872,416 0.23 872,416 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 71,302,057 18.64 71,266,057 214
2] Non Institution
Bodies Corporate 28,366,751 7.41 28,362,751 700
Clearing Members 4,201 0.00 4,201 3
Directors of their Relatives 713,259 0.19 713,259 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,438,285 0.64 2,438,285 2,698
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 782,919 0.20 782,419 1,232
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 703,799 0.18 703,799 2
Individuals holding nominal share capital up to Rs. 1 lakh 23,784,204 6.22 23,452,133 76,047
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,951 0.00 9,951 9
Others 348,638 0.09 348,638 1
Sub Total 57,186,913 14.95 56,850,342 80,694
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 382,567,140 100.00 382,194,569 80,910

Company Background

Cohance Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cohance Lifesciences Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    VIVEK SHARMA

  • Managing Director

    Venkatanaga Kali Vara Prasad Raju Vetukuri

  • Company Secretary

    Kundan Kumar Jha

  • Auditor

    Karvy & Co/Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cohance Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cohance Life 1,045.45 1,080.09 1,024.99 147.25 18.82
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10